Center for Structural Genomics of Infectious Diseases, Consortium for Advanced Science and Engineering, University of Chicago, Chicago, IL 60637.
Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL 60637.
Proc Natl Acad Sci U S A. 2021 May 25;118(21). doi: 10.1073/pnas.2100170118.
The genome of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronavirus has a capping modification at the 5'-untranslated region (UTR) to prevent its degradation by host nucleases. These modifications are performed by the Nsp10/14 and Nsp10/16 heterodimers using S-adenosylmethionine as the methyl donor. Nsp10/16 heterodimer is responsible for the methylation at the ribose 2'-O position of the first nucleotide. To investigate the conformational changes of the complex during 2'-O methyltransferase activity, we used a fixed-target serial synchrotron crystallography method at room temperature. We determined crystal structures of Nsp10/16 with substrates and products that revealed the states before and after methylation, occurring within the crystals during the experiments. Here we report the crystal structure of Nsp10/16 in complex with Cap-1 analog (GpppA). Inhibition of Nsp16 activity may reduce viral proliferation, making this protein an attractive drug target.
严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)冠状病毒的基因组在 5'非翻译区(UTR)具有加帽修饰,以防止其被宿主核酶降解。这些修饰由 Nsp10/14 和 Nsp10/16 异二聚体使用 S-腺苷甲硫氨酸作为甲基供体完成。Nsp10/16 异二聚体负责第一个核苷酸核糖 2'-O 位置的甲基化。为了研究 2'-O 甲基转移酶活性过程中复合物的构象变化,我们在室温下使用固定靶连续同步辐射晶体学方法。我们确定了带有底物和产物的 Nsp10/16 复合物的晶体结构,这些结构揭示了实验过程中晶体内部甲基化前后的状态。在这里,我们报告了 Nsp10/16 与 Cap-1 类似物(GpppA)复合物的晶体结构。抑制 Nsp16 的活性可能会减少病毒的增殖,使该蛋白成为一个有吸引力的药物靶标。